angiosarcoma in humans. The aim of this study was to describe histopathologic Franc ¸ois Mion, M.D. 1
p53 mutation pattern in hepatocellular carcinoma in workers exposed to vinyl chloride
✍ Scribed by Markus Weihrauch; Gerhard Lehnert; Ferdinand Köckerling; Christian Wittekind; Andrea Tannapfel
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 445 KB
- Volume
- 88
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
✦ Synopsis
Background:
Vinyl chloride (vc) is a known animal and human carcinogen that is associated with liver angiosarcoma and most likely also with hepatocellular carcinoma (hcc) in humans.
Methods:
The authors examined the presence of p53 gene mutations in 18 hcc specimens from patients with known exposure to vc (median, 8883 parts per million-years; median duration, 245 months). in all cases, other risk factors for the development of hcc (hepatitis b virus and hepatitis c virus infections, alcohol consumption, and metabolic or autoimmune disorders) were excluded. three patients had concomitant cirrhosis. the p53 gene was examined by direct sequencing of exons 5-9.
Results:
Mutations of the p53 gene were found in 11 of 18 hccs examined. the point mutations detected were comprised of five transversions and five transitions. five of 11 mutations (codons 175, 245, 248, 273, and 282) occurred at cpg sites. histopathologic liver alterations (mild sinusoidal dilatation, [portal] fibrosis, and centrilobular siderosis) in tumor surrounding nonneoplastic liver confirmed exposure to vc.
Conclusions:
The results of the current study indicated a relation between vc exposure and the development of hcc. the mutation pattern of p53 with a nearly equal rate of incidence of transitions and transversions and a high rate of incidence of mutations at cpg sites may reflect endogenous mechanisms (e.g., deamination of 5-methylcytosine) rather than exogenous carcinogens.
📜 SIMILAR VOLUMES
In some cases, evidence exists that exogenous carcinogenic exposures contribute to the mutation spectrum of the TP53 gene (p53) in human cancers. Although the clearest examples come from dietary and environmental sources, only a restricted number of papers have concentrated specifically on TP53 muta
BACKGROUND. Specific mutations of the p53 tumor suppressor gene in hepatocellular carcinoma (HCC) have been reported from several parts of the world, but to the authors' knowledge to date the status of this gene has not been studied in HCC patients in India, where HCC is one of the major cancers and
afflicted with both HCV and MC. Both Misiani et a1 and Lunel et be 'Ommended for their the mystery surrounding this fascinating group of patients. cryoglobulinemia patients: a randomized, crossover-controlled trial.
The cyclin-dependent kinase inhibitor p21/WAF1 is regulated by p53-dependent and p53-independent pathways. In addition, p21/WAF1 binds with proliferating cell nuclear antigen (PCNA) and inhibits the action of PCNA. To investigate the possible role of p21/WAF1 in human hepatocellular carcinomas (HCCs